3 February 2015
Biofortuna Ltd closes a £1.5m funding round
Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current...

20 January 2015
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim
Oxford BioTherapeutics Grants an Exclusive License to Boehringer Ingelheim for Development and Commercialization of Antibody Products to an Oncology Target … OXFORD, England, January 14, 2015 /PRNewswire/ -- Oxford BioTherapeutics announces today that Boehringer Ingelheim has...

13 January 2015
Antitope, INSERM and Baylor Institute to collaborate to produce manufacturing cell lines for two novel vaccines for HIV
Cambridge, UK – Antitope Limited (“Antitope”), an Abzena company (AIM: ABZA) that provides services and technologies to enable the development of better biopharmaceuticals, announces that it has extended its relationship with INSERM, the French National...